Please Wait
Applying Filters...
menu
    • menu
    Default Key Product, Service and Excipients
    News
    Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis

    08 May 2024

    // PRESS RELEASE

    Tiefenbacher Group Renovation Of Headquarters In Hamburg

    02 May 2024

    // PRESS RELEASE

    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.

    09 Apr 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Tiefenbacher Group

    Contact Supplier

    Website

    AGGSpend

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
    Left Arrow
    Right Arrow

    We are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    Related CompaniesRelated Companies

    About

    As a key component of the TIEFENBACHER GROUP, a 100% family-owned leader in healthcare, we offer comprehensive solutions across the entire life cycle of pharmaceutical products. Our expertise spans the development, manufacturing, and registration of generic, value-added, and innovative medicines, along with e-health solutions tailored for our B2B clients & distribution partners. Trusted globally, our outstanding capabilities in crafting top-tier dossiers and managing intricate product launches in over 80 countries. Our in-house laboratories and manufacturing facilities in India and Cyprus enable us to establish efficient supply chains.